Intravesical Gentamicin to Prevent Recurrent UTI

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Recurrent Uti
Interventions
DRUG

Gentamicin

administered via bladder

DRUG

Nitrofurantoin

administered PO

Trial Locations (1)

02903

RECRUITING

Women & Infants Hospital, Providence

All Listed Sponsors
lead

Women and Infants Hospital of Rhode Island

OTHER